Objectives The association between smoking and patients with schizophrenia has been established through epidemiological ...

Johnson & Johnson (NYSE:JNJ) is one of the most undervalued NYSE stocks to buy now. On July 8, Johnson & Johnson announced ...

Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions ...

After a season of regulatory upheaval, obesity and rare genetic diseases will likely remain major themes for biopharma in ...

Medically reviewed by Michael MacIntyre, MDSchizophrenia medication falls under two main categories: older, first-generation, or "typical" antipsychotics and newer drugs for schizophrenia known as ...

Some individuals living with obesity and overweight may find it difficult to embark on a weight loss journey alone. It’s not ...

Washingtonians with schizophrenia are curious about a recently FDA-approved drug to treat their symptoms but much is unknown about how well it works.

An antipsychotic medication often prescribed to people with schizophrenia or bipolar is in short supply.

Discover the top 19 most notable drugs approved by the FDA in 2024, including Dupixent for COPD and FluMist for self-administration. See the full list here.

The significant unmet need in schizophrenia, particularly in addressing both positive and negative symptoms, remains a critical challenge, and LB-102 is uniquely poised to bridge this gap.